Drug Treatment for Alcoholics With Bipolar Disorder
Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effectiveness of sodium valproate (Depacon) in
treating individuals with alcohol dependence and comorbid bipolar disorder.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)